Team finds flawed data in recent study relevant to coronavirus antiviral development
Thursday, July 3, 2025 - 12:17
in Health & Medicine
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an enzyme region essential to viral replication that's common to many coronaviruses.